결핵 진료지침

# 참고문헌

1.  Saukkonen JJ, Cohn DL, Jasmer RM, ATS (American Thoracic Society) Hepatotoxicity of Antituberculosis Therapy Subcommittee, et al. An official ATS statement: Hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med. 2006;174(8):935-952. doi:10.1164/rccm.200510-1666ST.
2.  Yee D, Valiquette C, Pelletier M, Parisien I, Rocher I, Menzies D. Incidence of Serious Side Effects from First-Line Antituberculosis Drugs among Patients Treated for Active Tuberculosis. Am J Respir Crit Care Med. 2003;167(11):1472-1477. doi:10.1164/rccm.200206-626OC.
3.  Canadian tuberculosis standard, 8th edition, chapter 10: Treatment of active tuberculosis in special populations. 2022.
4.  WHO. Operational handbook on tuberculosis, Web Annexes. 2022.
5.  Curry interantional tuberculosis center, 3th edition, comorbidities & special situations, 2022 update.
6.  WHO. Treatment of tuberculosis guideline. Fourth edition. 2010.
7.  Saukkonen JJ, Cohn DL, Jasmer RM, et al. An official ATS statement: hepatotoxicity of antituberculosis therapy. American journal of respiratory and critical care medicine. Oct 15 2006;174(8):935-952.

<PAGE>158
IV. 특수한 상황에서의 결핵치료